Investors in Venture Capita

Nextech Venture is a global investment management firm based in Zurich, Switzerland, which manages and advises the first world-wide oncology fund, launched in late 2006, fully dedicated to foster leading cancer companies including therapeutics, diagnostics, and medical devices.

DAA Capital Partners is a responsible Swiss-based private equity firm investing in impactful trends. We create value through long-term partnerships with outstanding teams and investors by leveraging our multidisciplinary expertise and our global network.

V-Sharp Venture Studio is a venture capital company focused on early stage investments in Central and Eastern Europe. V-Sharp Venture Studio is an experienced investment group focusing on early-stage investments in logistics, e-commerce, and fintech, providing strategic guidance and support to founders.

Sienna Venture Capital is the tech investment branch of the group Sienna Investment Managers. Our team is the largest European investor in Israeli tech, and we are launching a fund dedicated to the Israeli tech ecosystem: Sienna Startup Nation. Our mission is to implement a "tech for purpose" approach, and as committed investors, we aim to have a positive impact on environmental or societal issues by supporting companies that provide solutions to these challenges. With over 40 years of cumulative experience in the tech ecosystem, we identify trends and challenges among early-growth/growth companies in sectors such as digital health, climate, mobility, cybersecurity, agritech, foodtech, and artificial intelligence, among others.

Reference Capital is a privately held advisory firm dedicated to researching and investing in disruptive technologies which will transform the world we live in. Our team is composed of seasoned VC investors and family office managers primarily based in Geneva, Switzerland with presence in London, New York, Seattle, Tel Aviv, and Dubai. Reference Capital has built the ecosystem needed to find, track and access best-in-class Venture Funds that will drive outperformance for our clients. We provide investment advisory services to institutional investors, including some of the most influential industrial families, foundations, pensions, private clients, corporate and government entities.

Omega Funds is a leading international investment firm that creates and invests in life sciences companies that target the world's most urgent medical needs. Ω is the last letter of the Greek alphabet. Our investment process starts by focusing on the end goal – delivering impactful medicines to patients. We aim to invest in exceptional founders and entrepreneurs and impactful products and platforms across multiple therapeutic areas, including oncology, immunology, rare diseases, precision medicine and others. Early seed or late stage public financing. Large markets or rare diseases. Established targets or novel technologies.

ODYSSEE Venture, established in 1999, is a French Venture Capital and Private Equity player and one of the first independent private equity asset management companies accredited by AMF. Specializing in growth companies, we have raised over €600 million.

At NewAlpha Asset Management, we provide qualified investors with exclusive access to the most innovative and dynamic firms in the financial industry through a comprehensive range of products and services. Acting on behalf of our clients, we select, finance, and support innovative entrepreneurial projects primarily in asset management, as well as related sectors such as financial technologies and services for investment managers. As Europe's leading specialist in emerging manager seeding for institutional investors, we have established over 70 strategic partnerships and invested more than 1.5 billion euros in French and international investment management boutiques. Recognized as one of the world's most active allocators in this space, we have allocated over $500 million through 18 partnerships since 2011. NewAlpha Asset Management operates under the regulatory oversight of the Autorité des Marchés Financiers (AMF) and is a subsidiary of La Française Group and MACIF.

We have taken over 70 companies to a successful exit since setting up the Novartis Venture Fund in 1996 – that is three on average per year. These exits have primarily resulted in IPOs and M&As, with several drugs receiving FDA approval. Nearly 40 companies completed initial public offerings (IPO) Over 30 progressed to a merger and acquisition by a number of top pharmaceutical companies.

Why we are unique: Emerald brings open innovation and venture capital together in unparalleled fashion, with 20+ years of experience in investing in the sustainable industrial transformation. What we do: We empower corporates to successfully innovate and collaborate with start-ups, and to transition their businesses to a more sustainable future. We have over 50 large corporations as investors and partners in open innovation. How we do it: We invest in early and expansion stage start-ups globally, while being locally positioned in Europe, North America and Asia with a team of specialists from 15+ countries. Our sectors: energy, water & wastewater, food and agriculture, mobility & urbanization, materials & packaging, industrial IT About Emerald: Emerald is a globally recognized venture capital firm founded in 2000, that manages and advises assets of over €1 billion from its offices in Zurich, Toronto and Singapore.

Five Seasons Ventures is the premier pan-European Venture Capital fund focused on consumer brands, specializing in food-tech investments across the value chain to foster a healthier, more efficient, and sustainable system. We seek future category leaders exhibiting high growth potential, proven technology, and early commercial traction, typically at Series A or B stages. However, we also consider pre-revenue companies with exceptional promise at the Seed stage. Our initial investment ranges from €2-10 million, securing a significant minority stake and a board seat. We prefer syndicated investments with value-add investors and can deploy up to €20 million per company. With a team boasting over 40 years of cumulative VC experience, including 15+ years in food and ag investing, and over 30 years of operational expertise in the industry, we bring deep insights and networks to our portfolio. Supported by strategic and financial investors, we provide access to critical business and financing opportunities. As long-term investors, we leverage our industry knowledge to create enduring value and aim for successful exits for our portfolio companies.

We at TotalEnergies On are excited to support startups developing innovative solutions in the electricity and renewable energy sectors. Our objective is to detect and nurture the most promising startups in these fields. We are investing heavily to become one of the world's Top 5 renewable electricity producers by 2030, and you can play an active role in this exciting transition of our activities. Interested in applying? All information and the application form are available below.